Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aristoleo is a health-tech company focused on the measurement and certification of health-promoting compounds in extra virgin olive oil. The company's core technology is the Aristoleo Test Kit, a patented colorimetric assay used to quantify oleocanthal and oleacein, which are polyphenols linked to various health benefits. Aristoleo collaborates with academic institutions to support clinical trials investigating the impact of high-phenolic olive oil on neurodegenerative diseases and cardiovascular health. Additionally, the company provides a certification standard and hosts the Aristoleo Awards to recognize high-quality producers globally. Their work bridges the gap between traditional food production and modern medical research by providing tools for standardized health claim verification. The company also operates the Aristoleo DataBoard, a platform for tracking the phenolic content of olive oils over time.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aristoleo.